The novel findings of this study suggest that CMS2 cancers generally lack mucin, which is reflected not only in the quantification of extracellular mucin to-tumor area resulting from our algorithm, but also in analysis of mucin-related genes and proteins in two different publicly available datasets. This evidence concerns the gene MUC5AC and cancer.